Bioavailability of Tebipenem (SPR994) Crushed Tablet

Clinical trial NCT05296382 · COMPLETED

Trial details

NCT number: NCT05296382
Sponsor: Hartford Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relative Bioavailability

Start date: 2022-04-01
Primary completion: 2022-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.